9.86
Finanzdaten der Corbus Pharmaceuticals Holdings Inc-Aktie (CRBP)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
21.83%
1.314
|
1.681 | 3.554 | 1.189 | 0.906 |
|
3.15%
19.15
|
19.77 | 12.61 | 15.51 | 10.99 |
Benefits Costs and Expenses |
1.70%
18.98
|
18.66 | 13.08 | 14.97 | 10.90 |
Costs And Expenses |
1.70%
18.98
|
18.66 | 13.08 | 14.97 | 10.90 |
Depreciation and Amortization |
34.57%
0.053
|
0.081 | 0.134 | 0.152 | 0.1503 |
Operating Income/Loss |
3.15%
-19.15
|
-19.77 | -12.61 | -15.51 | -10.99 |
Nonoperating Income/Loss |
46.73%
1.49
|
2.797 | 3.075 | 1.722 | 0.991 |
Income/Loss From Continuing Operations Before Tax |
4.03%
-17.66
|
-16.98 | -9.53 | -13.78 | -9.997 |
Income/Loss From Continuing Operations After Tax |
4.03%
-17.66
|
-16.98 | -9.53 | -13.78 | -9.997 |
|
4.03%
-17.66
|
-16.98 | -9.53 | -13.78 | -9.997 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.31%
12.24
|
12.20 | 0.4244 | 12.01 | 11.05 |
Diluted Average Shares |
0.31%
12.24
|
12.20 | 0.4244 | 12.01 | 11.05 |
Basic Earnings Per Share |
3.60%
-1.44
|
-1.39 | -0.76 | -1.15 | -0.90 |
Diluted Earnings Per Share |
3.60%
-1.44
|
-1.39 | -0.76 | -1.15 | -0.90 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):